Cargando…
Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381563/ https://www.ncbi.nlm.nih.gov/pubmed/35597869 http://dx.doi.org/10.1038/s41416-022-01838-y |
_version_ | 1784769107179077632 |
---|---|
author | Konishi, Daisuke Umeda, Yuzo Yoshida, Kazuhiro Shigeyasu, Kunitoshi Yano, Shuya Toji, Tomohiro Takeda, Sho Yoshida, Ryuichi Yasui, Kazuya Fuji, Tomokazu Matsumoto, Kazuyuki Kishimoto, Hiroyuki Michiue, Hiroyuki Teraishi, Fuminori Kato, Hironari Tazawa, Hiroshi Yanai, Hiroyuki Yagi, Takahito Goel, Ajay Fujiwara, Toshiyoshi |
author_facet | Konishi, Daisuke Umeda, Yuzo Yoshida, Kazuhiro Shigeyasu, Kunitoshi Yano, Shuya Toji, Tomohiro Takeda, Sho Yoshida, Ryuichi Yasui, Kazuya Fuji, Tomokazu Matsumoto, Kazuyuki Kishimoto, Hiroyuki Michiue, Hiroyuki Teraishi, Fuminori Kato, Hironari Tazawa, Hiroshi Yanai, Hiroyuki Yagi, Takahito Goel, Ajay Fujiwara, Toshiyoshi |
author_sort | Konishi, Daisuke |
collection | PubMed |
description | BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome Atlas (TCIA) were assessed to determine the prognostic impact of immunogenicity in ICC and key components after curative resection. We also investigated the clinical relevance of the immune milieu in ICC. RESULTS: Using the Gene Expression Omnibus dataset 89749 and TCIA, we identified CD8(+)/forkhead box P3 (FoxP3)(+) tumour-infiltrating lymphocytes (TILs), T-cell immunoglobulin and mucin domain 3 (TIM-3) and human leukocyte antigen-A (HLA-A) in highly immunogenic ICCs. Immunohistochemical analysis of the in-house cohort showed that intratumoral FoxP3(+) TILs correlated with CD8(+) TILs (P = 0.045, Fisher’s exact test) and that high FoxP3(+)/CD8(+) ratio (FCR) was an important marker for poor survival (P < 0.001, log-rank test). Furthermore, the FCR was higher in tumour-free lymph nodes in ICCs with lymph node metastases than in those without lymph node metastases (P = 0.003, Mann–Whitney U test). CONCLUSIONS: FCR should be considered an important biomarker that represents the immune environment of ICC based on its potentially important role in tumour progression, especially lymph node metastasis. |
format | Online Article Text |
id | pubmed-9381563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93815632022-08-18 Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma Konishi, Daisuke Umeda, Yuzo Yoshida, Kazuhiro Shigeyasu, Kunitoshi Yano, Shuya Toji, Tomohiro Takeda, Sho Yoshida, Ryuichi Yasui, Kazuya Fuji, Tomokazu Matsumoto, Kazuyuki Kishimoto, Hiroyuki Michiue, Hiroyuki Teraishi, Fuminori Kato, Hironari Tazawa, Hiroshi Yanai, Hiroyuki Yagi, Takahito Goel, Ajay Fujiwara, Toshiyoshi Br J Cancer Article BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome Atlas (TCIA) were assessed to determine the prognostic impact of immunogenicity in ICC and key components after curative resection. We also investigated the clinical relevance of the immune milieu in ICC. RESULTS: Using the Gene Expression Omnibus dataset 89749 and TCIA, we identified CD8(+)/forkhead box P3 (FoxP3)(+) tumour-infiltrating lymphocytes (TILs), T-cell immunoglobulin and mucin domain 3 (TIM-3) and human leukocyte antigen-A (HLA-A) in highly immunogenic ICCs. Immunohistochemical analysis of the in-house cohort showed that intratumoral FoxP3(+) TILs correlated with CD8(+) TILs (P = 0.045, Fisher’s exact test) and that high FoxP3(+)/CD8(+) ratio (FCR) was an important marker for poor survival (P < 0.001, log-rank test). Furthermore, the FCR was higher in tumour-free lymph nodes in ICCs with lymph node metastases than in those without lymph node metastases (P = 0.003, Mann–Whitney U test). CONCLUSIONS: FCR should be considered an important biomarker that represents the immune environment of ICC based on its potentially important role in tumour progression, especially lymph node metastasis. Nature Publishing Group UK 2022-05-21 2022-09-01 /pmc/articles/PMC9381563/ /pubmed/35597869 http://dx.doi.org/10.1038/s41416-022-01838-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Konishi, Daisuke Umeda, Yuzo Yoshida, Kazuhiro Shigeyasu, Kunitoshi Yano, Shuya Toji, Tomohiro Takeda, Sho Yoshida, Ryuichi Yasui, Kazuya Fuji, Tomokazu Matsumoto, Kazuyuki Kishimoto, Hiroyuki Michiue, Hiroyuki Teraishi, Fuminori Kato, Hironari Tazawa, Hiroshi Yanai, Hiroyuki Yagi, Takahito Goel, Ajay Fujiwara, Toshiyoshi Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
title | Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
title_full | Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
title_fullStr | Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
title_full_unstemmed | Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
title_short | Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
title_sort | regulatory t cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381563/ https://www.ncbi.nlm.nih.gov/pubmed/35597869 http://dx.doi.org/10.1038/s41416-022-01838-y |
work_keys_str_mv | AT konishidaisuke regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT umedayuzo regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT yoshidakazuhiro regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT shigeyasukunitoshi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT yanoshuya regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT tojitomohiro regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT takedasho regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT yoshidaryuichi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT yasuikazuya regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT fujitomokazu regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT matsumotokazuyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT kishimotohiroyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT michiuehiroyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT teraishifuminori regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT katohironari regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT tazawahiroshi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT yanaihiroyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT yagitakahito regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT goelajay regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma AT fujiwaratoshiyoshi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma |